Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
Apr 02, 06:43 PM
Share
Subscribe
In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi enters a $2 billion agreement to acquire rights to Radicava, and the FTC examines antitrust concerns tied to CVS Health’s integrated healthcare model.